A Study in Prevention of Re-emergence of Depression Symptoms

NCT01299272 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1249

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Placebo
DRUG: SSRI

Sponsor

Eli Lilly and Company